Select for export Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX SSRN Electronic Journal 2019-12-29 Krishna Kumar Varshney OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.271 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange OpenAlex Published psilocybin PharmacologyOxidative Stress Other More
Select for export P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.232 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel OpenAlex Published psilocybin Receptor PharmacologyPersonality Change Other More
Select for export P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.593 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris OpenAlex Published psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial More
Select for export P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.702 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Psilocybin-assisted therapy for depression: How do we advance the field? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0004867419888575 PubMed 31752499 Copy citation Copy BibTeX Australian & New Zealand Journal of Psychiatry 2019-11-21 Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas OpenAlex Published psilocybin DepressionPharmacologyMechanism of Action Other More
Select for export Modified E. coli pump out psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-09739-scicon9 Copy citation Copy BibTeX C&EN Global Enterprise 2019-10-06 Megha Satyanarayana OpenAlex Published psilocybinpsilocin DepressionPharmacologyMechanism of Action Clinical Trial More
Select for export Psychedelic microdosing benefits and challenges: an empirical codebook Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12954-019-0308-4 PubMed 31288862 Copy citation Copy BibTeX Harm Reduction Journal 2019-07-08 Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory R. Weissman, Lê-Anh Dinh-Williams OpenAlex Published psilocybin AnxietyChronic PainPharmacology Qualitative Study More
Select for export The Potential of Psilocybin Administration in Terminal Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000574916.46844.cf Copy citation Copy BibTeX Oncology Times 2019-06-27 Richard Simoneaux OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Replication and extension of a model predicting response to psilocybin No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-019-05279-z PubMed 31203401 Copy citation Copy BibTeX Psychopharmacology 2019-06-14 Suzanne L. Russ, Robin Carhart-Harris, Geoffrey Maruyama, Melody S. Elliott OpenAlex Published psilocybin AnxietyPharmacologyToxicity Other More
Select for export Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cbic.201900358 PubMed 31150155 Copy citation Copy BibTeX ChemBioChem 2019-05-30 Janis Fricke, Alexander M. Sherwood, Robert B. Kargbo, Andrew Orry, Felix Blei, Andreas Naschberger OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Motives and Side-Effects of Microdosing With Psychedelics Among Users Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyz029 PubMed 31152167 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2019-05-29 Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers OpenAlex Published psilocybin PharmacologyMicrodosingObservational Study Observational Study More
Select for export Psychedelics Improve the Mental Health of Rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.2019.33.1_supplement.666.1 Copy citation Copy BibTeX The FASEB Journal 2019-03-31 Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-019-0324-9 PubMed 30685771 Copy citation Copy BibTeX Neuropsychopharmacology 2019-01-25 M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen OpenAlex Published psilocybinpsilocin PharmacologyReceptor Pharmacology Other More
Select for export Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000253 PubMed 30628811 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2019-01-09 Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus OpenAlex Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export Psilocybin induces aberrant prediction error processing for tactile mismatch responses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.477 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 P. Dürler OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.474 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel OpenAlex Published psilocybinpsilocin Receptor Pharmacology Other More
Select for export Production Options for Psilocybin: Making of the Magic. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/chem.201802758 PubMed 30011099 Copy citation Copy BibTeX Chemistry - A European Journal 2018-11-14 Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D. Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Clinical Trial More
Select for export Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881118793086 PubMed 30182795 Copy citation Copy BibTeX Journal of Psychopharmacology 2018-09-04 Leonard JB, Anderson B, Klein-Schwartz W. Europe PMC Published psilocybin AdolescentsSafetyToxicity Other More
Select for export d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.pbr.2018.07.008 PubMed 30471683 Copy citation Copy BibTeX Unknown journal 2018-08-30 De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. Europe PMC Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
